U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C51H98O6
Molecular Weight 807.3202
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TRIPALMITIN

SMILES

CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC

InChI

InChIKey=PVNIQBQSYATKKL-UHFFFAOYSA-N
InChI=1S/C51H98O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-49(52)55-46-48(57-51(54)45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)47-56-50(53)44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h48H,4-47H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C51H98O6
Molecular Weight 807.3202
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Tripalmitin is a triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by palmitic (hexadecanoic) acid. It derives from a hexadecanoic acid. Tripalmitin is used as a skin conditioning agent.

Approval Year

PubMed

PubMed

TitleDatePubMed
Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency.
2010-09
A rapid separation technique for overcoming suppression of triacylglycerols by phosphatidylcholine using MALDI-TOF MS.
2010-08
Optimisation of tripalmitin-rich fractionation from palm stearin by response surface methodology.
2010-07
Evolving neural network optimization of cholesteryl ester separation by reversed-phase HPLC.
2010-07
Regulation of hepatic gene expression by saturated fatty acids.
2010-03-16
Two-step solid lipid extrusion as a process to modify dissolution behavior.
2010-03
Investigating the relationship between drug distribution in solid lipid matrices and dissolution behaviour using Raman spectroscopy and mapping.
2010-03
Screening of food grade lipases to be used in esterification and interesterification reactions of industrial interest.
2010-02
Cellular stress responses: cell survival and cell death.
2010
Fatty acid selectivity of lipases during acidolysis reaction between oleic acid and monoacid triacylglycerols.
2009-11-11
Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase.
2009-09-29
Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles.
2009-09-09
Thermostable lipases from the extreme thermophilic anaerobic bacteria Thermoanaerobacter thermohydrosulfuricus SOL1 and Caldanaerobacter subterraneus subsp. tengcongensis.
2009-09
Lipase-catalyzed reactions at interfaces of two-phase systems and microemulsions.
2009-09
Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures.
2009-08-04
Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion.
2009-07-16
Influence of structural variations on drug release from lipid/polyethylene glycol matrices.
2009-07-12
Solid lipid nanoparticles: a modern formulation approach in drug delivery system.
2009-07
Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
2009-06-01
Effect of electromagnetic field and surface modification on the electrical behavior of novel solid lipid nanoparticles covered with l-arginine.
2009-06-01
Biochemical characterization of a putative wheat caffeic acid O-methyltransferase.
2009-04
Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials.
2009-02
Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution.
2009-01
Nanomedicine in pulmonary delivery.
2009
Biosynthesis of storage compounds by Rhodococcus jostii RHA1 and global identification of genes involved in their metabolism.
2008-12-12
Plant products for pharmacology: application of enzymes in their transformations.
2008-12
Polaron hopping in some biomolecular solids and their charge transfer complexes.
2008-12
Temperature scanning ultrasonic velocity study of complex thermal transformations in solid lipid nanoparticles.
2008-11-18
Modeling of the triglyceride-rich core in lipoprotein particles.
2008-11-06
Construction of a taste-blind medaka fish and quantitative assay of its preference-aversion behavior.
2008-11
Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon.
2008-09
Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla.
2008-09
Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets.
2008-09
Lipid droplets: a classic organelle with new outfits.
2008-08
Structure-activity relationships of wheat flavone O-methyltransferase: a homodimer of convenience.
2008-05
Micro-scale flow cytometry-based and biochemical analysis of lipid signaling in primary B cell subpopulations.
2007-12-24
Ultrasonic scattering in chocolate and model systems containing sucrose, tripalmitin and olive oil.
2007-11
Slow recrystallization of tripalmitoylglycerol from MCT oil observed by 2H NMR.
2007-10-17
Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic beta-cells.
2007-08
Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications.
2007-07-12
Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
2007-07-10
Enzymatic production of infant milk fat analogs containing palmitic acid: optimization of reactions by response surface methodology.
2007-05
Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
2007-04-20
Enzymatic interesterification of tripalmitin with vegetable oil blends for formulation of caprine milk infant formula analogs.
2007-02
High-temperature micro liquid chromatography for lipid molecular species analysis with evaporative light scattering detection.
2007-01-26
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.
2007
[Effect of crystallization temperature of palm oil on its crystallization. IV. The influence of tripalmitoylglycerol (PPP) on the crystallization of 1,3-dipalmitoyl-2-oleoyl-glycerol (POP) and 1,2-dioleoyl-3-palmitoyl-glycerol (POO)].
2007
Tripalmitin-based cationic lipospheres: preparation, characterization and in Lab-on-a-chip applications.
2006-11-28
Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
2006-11
Human milk fat substitutes containing omega-3 fatty acids.
2006-05-17
Patents

Sample Use Guides

Mice: tripalmitin (0--250 g fat/kg)
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:56:51 GMT 2025
Edited
by admin
on Mon Mar 31 17:56:51 GMT 2025
Record UNII
D133ZRF50U
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TRIPALMITIN
INCI   INN   MI  
INCI   INN  
Official Name English
BAROLUB LCD
Preferred Name English
tripalmitin [INN]
Common Name English
1,2,3-PROPANETRIYL TRIHEXADECANOATE
Systematic Name English
DYNASAN 116
Brand Name English
TRIPALMITIN [MI]
Common Name English
TRIPALMITOYLGLYCEROL
Systematic Name English
SPEZIALFETT 116
Brand Name English
GLYCEROL TRIPALMITATE
Systematic Name English
GLYCERYL TRIHEXADECANOATE
Systematic Name English
HEXADECANOIC ACID, 1,1',1''-(1,2,3-PROPANETRIYL) ESTER
Common Name English
DYNOSAN 114
Brand Name English
GLYCERYL TRIPALMITATE
Systematic Name English
PALMITIC ACID TRIGLYCERIDE
Common Name English
HEXADECANOIC ACID, 1,2,3-PROPANETRIYL ESTER
Common Name English
Code System Code Type Description
WIKIPEDIA
TRIPALMITIN
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
MERCK INDEX
m11178
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY Merck Index
PUBCHEM
11147
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
MESH
C005859
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
ChEMBL
CHEMBL2002154
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
SMS_ID
100000076948
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
FDA UNII
D133ZRF50U
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
EPA CompTox
DTXSID8046169
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
ECHA (EC/EINECS)
209-098-1
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
DAILYMED
D133ZRF50U
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
CONCEPT Industrial Aid
INN
6950
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
CHEBI
77393
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
NCI_THESAURUS
C78766
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
CAS
555-44-2
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
EVMPD
SUB11319MIG
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY
RXCUI
1368169
Created by admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
PRIMARY RxNorm
Related Record Type Details
ACTIVE MOIETY